Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC PROTAC BCR-ABL Degrader-1 | 3079412-59-9 | C43H40N10O6 | 5 MG
SDP

Catalog No. 5000373533
Encompass_Preferred

PROTAC BCR-ABL Degrader-1, also known as compound PROTAC 1, is a PROTAC (Proteolysis Targeting Chimera) featuring a 2-oxoethyl linker. This compound functions by inducing Bcr-Abl degradation through a ubiquitin-proteasome-dependent mechanism. It has demonstrated antiproliferative activity against K562 cells, indicating its potential for use in cancer research.

  • Utilizes a PROTAC approach with a 2-oxoethyl linker.
  • Induces Bcr-Abl degradation.
  • Operates via a ubiquitin-proteasome-dependent manner.
  • Exhibits antiproliferative activity against K562 cells.
  • Has the potential for studying cancer.

Catalog No. 50-003-73533 Supplier Medchemexpress LLC Supplier No. HY1534155MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

PROTAC BCR-ABL Degrader-1, also known as compound PROTAC 1, is a PROTAC (Proteolysis Targeting Chimera) featuring a 2-oxoethyl linker. This compound functions by inducing Bcr-Abl degradation through a ubiquitin-proteasome-dependent mechanism. It has demonstrated antiproliferative activity against K562 cells, indicating its potential for use in cancer research.

  • Utilizes a PROTAC approach with a 2-oxoethyl linker.
  • Induces Bcr-Abl degradation.
  • Operates via a ubiquitin-proteasome-dependent manner.
  • Exhibits antiproliferative activity against K562 cells.
  • Has the potential for studying cancer.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.